The INVENT COVID trial: a structured protocol for a randomized controlled trial investigating the efficacy and safety of intravenous imatinib mesylate (Impentri®) in subjects with acute respiratory distress syndrome induced by COVID-19
Atmowihardjo, Leila, Schippers, Job R, Bartelink, Imke H, Bet, Pierre M, van Rein, Nienke, Purdy, Keith, Cavalla, David, Comberiati, Valérie, McElroy, Andrew, Snape, Sue D, Bogaard, Harm Jan, Heunks, Leo, Juffermans, Nicole, Schultz, Marcus, Tuinman, Pieter R, Bos, Lieuwe D J, Aman, Jurjan
Published in Current controlled trials in cardiovascular medicine (16.02.2022)
Published in Current controlled trials in cardiovascular medicine (16.02.2022)
Get full text
Journal Article
Elevated acute phase proteins affect pharmacokinetics in COVID‐19 trials: Lessons from the CounterCOVID ‐ imatinib study
Bartelink, Imke H., Bet, Pierre M., Widmer, Nicolas, Guidi, Monia, Duijvelaar, Erik, Grob, Bram, Honeywell, Richard, Evelo, Amanda, Tielbeek, Ivo P. E., Snape, Sue D., Hamer, Henrike, Decosterd, Laurent A., Jan Bogaard, Harm, Aman, Jurjan, Swart, Eleonora L.
Published in CPT: Pharmacometrics & Systems Pharmacology (01.12.2021)
Published in CPT: Pharmacometrics & Systems Pharmacology (01.12.2021)
Get full text
Journal Article
Web Resource